VitalOne™: a point-of-care platform for rapid, comprehensive, central-lab quality blood testing†

IF 3.5 Q2 CHEMISTRY, ANALYTICAL Sensors & diagnostics Pub Date : 2024-11-11 DOI:10.1039/D4SD00105B
Mounir A. Koussa, Miguel Barreiros, Paul Said Ehrlich Perez, Sae Rin Jean, Taehyung Chris Lee, Ross MacLeod, Aaron Witham, Geeta Bhat, Todd Campbell, Sergio Lizano, Marjorie Toth, Amrita Venkateswaran, Don Yang, Nishat Zaman, Wisam Alfaqheri, Afshan Ardalan, Luis Barbosa, Mehran Behrouzi, Vitali Borisenko, Rohit Chand, Karyn S. Ho, Praveen Kumar, Mate Lengyel, Wei Luo, Fahim Masum, Laura Piñeros, Akhil Rajagopal Kozhipuram, Sergey Sanders, David Santos, Vasu Nadella, Farnoud Kazemzadeh and Iman Khodadad
{"title":"VitalOne™: a point-of-care platform for rapid, comprehensive, central-lab quality blood testing†","authors":"Mounir A. Koussa, Miguel Barreiros, Paul Said Ehrlich Perez, Sae Rin Jean, Taehyung Chris Lee, Ross MacLeod, Aaron Witham, Geeta Bhat, Todd Campbell, Sergio Lizano, Marjorie Toth, Amrita Venkateswaran, Don Yang, Nishat Zaman, Wisam Alfaqheri, Afshan Ardalan, Luis Barbosa, Mehran Behrouzi, Vitali Borisenko, Rohit Chand, Karyn S. Ho, Praveen Kumar, Mate Lengyel, Wei Luo, Fahim Masum, Laura Piñeros, Akhil Rajagopal Kozhipuram, Sergey Sanders, David Santos, Vasu Nadella, Farnoud Kazemzadeh and Iman Khodadad","doi":"10.1039/D4SD00105B","DOIUrl":null,"url":null,"abstract":"<p >Diagnostic tools are fundamental to informed healthcare decisions, but the current state of <em>in vitro</em> diagnostics presents barriers to providing timely access to a wide menu of tests. This paper discusses a method for overcoming these challenges with a novel and miniaturized point-of-care (PoC) solution, the VitalOne. While many PoC solutions have limited test menus tailored for specific scenarios, Vital Bio introduces a comprehensive test menu in a compact PoC format that uses centrifugal microfluidic workflows to deliver quantitative results across three modalities that have traditionally required three separate instruments. VitalOne has combined three modalities into a single instrument: hematology, clinical chemistry, and immunoassay. This breadth of central-lab quality results covers a wide variety of use cases and helps to eliminate the send-out gap that impedes the adoption of PoC technologies. This paper provides a comprehensive and transparent view of both our assay performance data and underlying methods of operation. By comparing the VitalOne system with established benchmarks commercialized devices including Roche cobas® c701, Sysmex 140, Beckman DxH® 500, Beckman AU® 480, and Beckman Access® 2 instrument systems, we demonstrate consistent assay performance, resilience to interference, and performance that is compliant with Clinical Laboratory Improvement Amendments (CLIA) total allowable error standards. Additionally, this article elucidates our system's operational intricacies and showcases performance data from a diverse set of analytes.</p>","PeriodicalId":74786,"journal":{"name":"Sensors & diagnostics","volume":" 12","pages":" 1899-1922"},"PeriodicalIF":3.5000,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://pubs.rsc.org/en/content/articlepdf/2024/sd/d4sd00105b?page=search","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sensors & diagnostics","FirstCategoryId":"1085","ListUrlMain":"https://pubs.rsc.org/en/content/articlelanding/2024/sd/d4sd00105b","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, ANALYTICAL","Score":null,"Total":0}
引用次数: 0

Abstract

Diagnostic tools are fundamental to informed healthcare decisions, but the current state of in vitro diagnostics presents barriers to providing timely access to a wide menu of tests. This paper discusses a method for overcoming these challenges with a novel and miniaturized point-of-care (PoC) solution, the VitalOne. While many PoC solutions have limited test menus tailored for specific scenarios, Vital Bio introduces a comprehensive test menu in a compact PoC format that uses centrifugal microfluidic workflows to deliver quantitative results across three modalities that have traditionally required three separate instruments. VitalOne has combined three modalities into a single instrument: hematology, clinical chemistry, and immunoassay. This breadth of central-lab quality results covers a wide variety of use cases and helps to eliminate the send-out gap that impedes the adoption of PoC technologies. This paper provides a comprehensive and transparent view of both our assay performance data and underlying methods of operation. By comparing the VitalOne system with established benchmarks commercialized devices including Roche cobas® c701, Sysmex 140, Beckman DxH® 500, Beckman AU® 480, and Beckman Access® 2 instrument systems, we demonstrate consistent assay performance, resilience to interference, and performance that is compliant with Clinical Laboratory Improvement Amendments (CLIA) total allowable error standards. Additionally, this article elucidates our system's operational intricacies and showcases performance data from a diverse set of analytes.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
VitalOne™:用于快速、全面、中央实验室质量血液检测的即时护理平台
诊断工具对知情的医疗保健决策至关重要,但体外诊断的现状对及时提供广泛的检测存在障碍。本文讨论了一种克服这些挑战的方法,一种新颖和小型化的护理点(PoC)解决方案,VitalOne。虽然许多PoC解决方案具有针对特定场景量身定制的有限测试菜单,但Vital Bio引入了紧凑PoC格式的全面测试菜单,该菜单使用离心微流体工作流程提供三种模式的定量结果,传统上需要三个独立的仪器。VitalOne将血液学、临床化学和免疫分析三种方法结合为一种仪器。中央实验室质量结果的广度涵盖了广泛的用例,并有助于消除阻碍PoC技术采用的发送差距。本文提供了我们的分析性能数据和操作的基本方法的全面和透明的观点。通过将VitalOne系统与已建立的基准商业化设备(包括罗氏cobas®c701, Sysmex 140, Beckman DxH®500,Beckman AU®480和Beckman Access®2仪器系统)进行比较,我们展示了一致的分析性能,抗干扰能力,以及符合临床实验室改进修正案(CLIA)总允许误差标准的性能。此外,本文阐明了我们系统的操作复杂性,并展示了来自不同分析集的性能数据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.30
自引率
0.00%
发文量
0
期刊最新文献
Back cover Rapid and automated interpretation of CRISPR-Cas13-based lateral flow assay test results using machine learning. Selection of ssDNA aptamers and construction of an aptameric electrochemical biosensor for detecting Giardia intestinalis cyst protein† Expression of concern: Sensing of COVID-19 spike protein in nasopharyngeal samples using a portable surface plasmon resonance diagnostic system Back cover
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1